Serious Infection Rates Among Patients With Systemic Lupus Erythematosus Receiving Corticosteroids and Immunosuppressants.

被引：0

作者：

Feldman, Candace H. ^{[1
]}

Hiraki, Linda T. ^{[2
]}

Marty, Francisco M. ^{[3
]}

Winkelmayer, Wolfgang C. ^{[4
]}

Franklin, Jessica M. ^{[5
]}

Solomon, Daniel H. ^{[6
]}

Kim, Seoyoung C. ^{[3
]}

Costenbader, Karen H. ^{[7
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA

[2] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Boston, MA 02115 USA

[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[5] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol,Div Pharmacoepidemiol, Boston, MA 02115 USA

[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

来源：

ARTHRITIS AND RHEUMATISM | 2013年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

780

引用

页码：S330 / S330

页数：1

共 50 条

[1] Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications
Feldman, Candace H.
Marty, Francisco M.
Winkelmayer, Wolfgang C.
Guan, Hongshu
Franklin, Jessica M.
Solomon, Daniel H.
Costenbader, Karen H.
Kim, Seoyoung C.
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 387 - 397
[2] Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid
Hiraki, Linda T.
Feldman, Candace H.
Marty, Francisco M.
Winkelmayer, Wolfgang C.
Guan, Hongshu
Costenbader, Karen H.
[J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1620 - 1626
[3] Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus?
Magder, Laurence S.
Fava, Andrea
Goldman, Daniel
Petri, Michelle A.
[J]. LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
[4] Polyomavirus viruria in pediatric patients with systemic lupus erythematosus receiving long term immunosuppressants
Rianthavorn, P.
Posuwan, N.
Payungporn, S.
Theanboonlers, A.
Poovorawan, Y.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E106 - E106
[5] Serious infection incidence rates in pediatric systemic lupus erythematosus according to medication use
Hiraki, Linda T.
Feldman, Candace H.
Son, Mary Beth
Franklin, Jessica M.
Fischer, Michael A.
Solomon, Daniel H.
Kim, Seoyoung C.
Winkelmayer, Wolfgang C.
Costenbader, Karen H.
[J]. ARTHRITIS RESEARCH & THERAPY, 2014, 16
[6] Serious infection incidence rates in pediatric systemic lupus erythematosus according to medication use
Linda T Hiraki
Candace H Feldman
Mary Beth Son
Jessica M Franklin
Michael A Fischer
Daniel H Solomon
Seoyoung C Kim
Wolfgang C Winkelmayer
Karen H Costenbader
[J]. Arthritis Research & Therapy, 16
[7] Comparative Rates of Serious Infections and All-Cause Mortality Among Systemic Lupus Erythematosus Patients Receiving Mycophenolate Mofetil Versus Azathioprine
Feldman, Candace H.
Marty, Francisco M.
Winkelmayer, Wolfgang C.
Guan, Hongshu
Franklin, Jessica M.
Solomon, Daniel H.
Kim, Seoyoung C.
Costenbader, Karen H.
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[8] Serious infections in patients with systemic lupus erythematosus
Goldblaft, F.
Rahman, A.
Isenberg, D. A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 464 - 465
[9] EFFECTS OF VARIOUS IMMUNOSUPPRESSANTS IN THE DISEASE DAMAGE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Shaharir, S. S.
Ding, H. J.
Rajalingham, S.
Said, M. S. Mohamed
Kong, N. C. T.
Hussein, H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 255 - 255
[10] Risk factor for serious infection during treatment with cyclophosphamide and high dose corticosteroids for systemic lupus erythematosus
BartzBazzanella, P
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1996, 55 (06): : 428 - 429

← 1 2 3 4 5 →